CereVasc Appoints Tony Kingsley as CEO Ahead of eShunt Commercial Launch

Boston, MA, September 15, 2026 (PR Newswire) -- CereVasc has appointed Tony Kingsley as President and Chief Executive Officer, effective September 15, succeeding Dan Levangie, who will transition to Chairman of the Board. Kingsley brings extensive commercial leadership experience in neurology and healthcare and will oversee the company’s strategy and operations as it prepares for the commercial introduction of its eShunt System. Levangie will continue supporting CereVasc’s strategic direction as Chairman following his tenure leading the company through clinical development and more than 200 eShunt procedures worldwide.

Read full article here.